000 | 01099 a2200277 4500 | ||
---|---|---|---|
005 | 20250516221544.0 | ||
264 | 0 | _c20140928 | |
008 | 201409s 0 0 eng d | ||
022 | _a1873-3735 | ||
024 | 7 |
_a10.1016/j.tips.2014.05.007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGeahlen, Robert L | |
245 | 0 | 0 |
_aGetting Syk: spleen tyrosine kinase as a therapeutic target. _h[electronic resource] |
260 |
_bTrends in pharmacological sciences _cAug 2014 |
||
300 |
_a414-22 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
650 | 0 | 4 | _aSyk Kinase |
773 | 0 |
_tTrends in pharmacological sciences _gvol. 35 _gno. 8 _gp. 414-22 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.tips.2014.05.007 _zAvailable from publisher's website |
999 |
_c23963071 _d23963071 |